Soligenix Receives Positive Scientific Advice from the European Medicines Agency for SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Mississippi News Now ,
SOURCE Soligenix, Inc. Follows UK Health Ministry's Granting SGX942 Promising Innovative Medicine Designation in the Treatment…